INTRODUCTION
Murine cytomegalovirus (MCMV) is a member of a sub-family of herpesviruses termed Betaherpesvirinae and as such is a useful model for the study of viral infections that usually result in non-fatal and latent illnesses. As part of the study of the immunobiology of MCMV infection we have investigated the cytotoxic T cell response to this virus, a response which may contribute to the clearance of infection (Ho, 1980; Sinickas et al., 1985a, b) . We have now utilized MCMV-immune lymph node (LN) cell populations to investigate the nature of T lymphocytes that release lymphokine after stimulation with MCMV. One particular lymphokine, interleukin-3 (IL-3), a glycoprotein belonging to a family of glycoproteins known as colonystimulating factors (CSF) that are essential for survival, growth and differentiation of haemopoietic progenitor cells in vitro (Ihle et al., 1983) has been used in this study. We present evidence that IL-3 release from the MCMV-immune LN cell population was dependent upon Thyl.2 ÷, Lyt2 ÷ cells that were triggered by Class I H-2-restricted and virus-specific antigen recognition; cytotoxic activity against MCMV-infected target cells was mediated by a phenotypically similar cell population.
METHODS
Mice. BALB/c, CBA/H, WEHI-3, B I0. T(6R) and B10. AQR mice were obtained from the Animal Breeding Establishment of the John Curtin School of Medical Research and used between 6 and 12 weeks of age.
Viruses. The Smith strain of MCMV was obtained from Dr G. Shellam, University of Western Australia, Nedlands. Salivary gland virus stock was prepared by intraperitoneal (i.p.) inoculation of 2 x 10 ~ p.f.u./0.2 ml 0000-6718©1985 SGM V. G. SINICKAS AND OTHERS into 4-week-old BA LB~ c t'cmale mice. At day 17 post-inoculation, salivary glands were harvested and a 50~ (w/v) homogenate was prepared in Dulbecco's modified Eagle's medium (cat. no. H l6, Gibco) , supplemented with 5 foetal calf serum (FCS) (t:low Laboratories), 200 }ag/ml streptomycin, 200 U/ml penicillin G and 125 I-tg/ml neomycin sulphate. (The complete medium is referred to hereafter as DMEM.) Aliquots were stored at -70 °C. For dilution of virus stock 0.2 M-borate-buffered gelatin saline (pH 7.2 to 7-4) was used. Influenza A/WSN was prepared by standard methods (Yap & Ada, 1977) .
Generation ¢?[antit'iral immune cells. Anti-MCM V immune LN cells were generated as described (Sinickas et al., 1985a, b) . Briefly, mice wcrc inoculated into hind footpads (f.p.) with 40 ~tl of MCMV (4 x 102 p.f.u.). Seven days after inoculation, the draining popliteal LN cells were harvested and cultured at 6 x l0 s cells/ml in 5 ml wells (Costar, cat. no. 3512 ) containing Eagle's MEM (EMEM) (cat. no. F-15, Gibco) supplemented with 10~ FCS, antibiotics, 10-* i-2-mercaptoethanol (2-ME, Sigma) and 3~ (v/v) supernatant from concanavalin A-stimulated spleen cells (CSS: see Sinickas et al., 1985a) . After 4 days incubation at 37 °C in 83~ N2, 7~ 02 and 10~ CO2 (special gas) (Common~eahh Industrial Gases, Alexandria, N.S.W., Australia) effector cells were harvested. Anti-influenza A/WSN eI1L, clor cells were generated by secondary cultures of primed spleen cells (Yap & Ada, 1977) . After 5 days incubation the cells were harvested and debris was removed by centrifugation through an Isopaque-Ficotl gradient.
Cell culture. Mouse embryo fibroblast (MEF) cultures were prepared from 16 to 18 day embryos by trypsin dispersion and growth in DMEM. Tissue culture flasks (75 cm 2, Nunc) were seeded at 2 x 106 cells/flask and incubated at 37 °C for 4 days in special gas, after which time the cells were either subcultured immediately or kept at room temperature for up to 2 weeks prior to subculture. Conditions of subculture were the same as described for primary cultures, except that these secondary MEF cells were always used after 4 days at 37 °C as the source for tertiary MEF target or stimulator cells. The DBA/2 mastocytoma cell line P-815-X2 (P815) was grown in DMEM at 37 °C in a humidified atmosphere containing 5~ CO, in air.
The IL-3-dependent cell line, FDC-PI (Dexter et al., 1980) , was grown in RPMI 1640 medium (cat. no. 10-601-20, Flow Laboratories) supplemented with 50/0 heat-inactivated FCS (HI-FCS) and 10~ WEHI-3B cell lineconditioned medium (kindly provided by Dr A. J. Hapel).
Preparation of stimulator ccllsfi~r lymphokine production. Secondary MEF were subcultured into 30 cm 2 plastic dishes (cat. no. P.D.S. 6515H, Kayline Plastics, Thebarton, South Australia) at 10 ° cells/10 ml DMEM, supplemented with 39 o (v/v) CSS/dish. The cells were incubated for 2 days at 37 °C in special gas, after which time the cell monolayers were washed twice with DMEM and adsorbed with l ml of 1:8 dilution of MCMV stock (4 × 107 p.f.u./ml) per dish. The cell monolayers were centrifuged at 800g for 20 rain at room temperature and then incubated at 37 °C in special gas for 40 rain. Subsequently l0 mt of DMEM was added and incubation continued for 16 h. Uninfected control MEF were subjected to the same protocol, except that no virus was added to the monolayer. At 16 h the cell monolayers were washed, trypsinized and resuspended in DMEM at 106 cells/ml, and l0 ml aliquots were then added to 65 cm 2 plastic Petri dishes (cat. no. 992550, Medical Plastics, Edwardstown, South Australia) and subjected to u.v. irradiation from an 80 W germicidal lamp for 4 min at an intensity of 960 I_tW/cm 2 in the 230 to 270 nm range. These cells were then washed twice and resuspended at an appropriate concentration in EMEM supplemented with 10 --t M-2-ME. Aliquots of 0.1 ml were dispensed into 96-well flatbottomed trays (Nunc). Serial twofold dilutions were prepared prior to addition of antiviral effector cells.
For P815 cells, 107 cells/500 Ixl DMEM were adsorbed with 200 M1 influenza A/WSN stock (haemagglutinin titre 1 : 1024) for 60 min, after which 5 ml DMEM was added and incubation continued for another 6 h. Subsequent treatment for the influenza A/WSN-infected and uninfected P815 was similar to that described for MEF.
Conditions[or stimulation oflymphokme production. Antiviral effector cells were harvested, washed twice and resuspended in EMEM supplemented with 10 -'~ M-2-ME at 5 × 106 cells/ml. One-hundred ~tl aliquots were dispensed into 96-well flat-bottomed plates containing 100 ~tl aliquots of infected or uninfected stimulator cells. These cell mixtures were incubated at 37 °C in special gas mixture for 6 h, after which time cell-free supernatants were removed and stored at -20 °C until assayed for IL-3.
IL-3 assay. IL-3 activity was assayed by measuring the ability of lymphokine preparations to maintain in vitro proliferation of the IL-3-dependent FDC-PI cell line. After a period of 16 to 24 h without IL-3, FDC-P1 cells cease dividing. Serial twofold dilutions of the test supernatants were prepared in 96-well flat-bottomed plates (Linbro cat. no. 76-203-05, Flow Laboratories) with 50 ~tl RPMI 1640 medium plus 5~ HI-FCS as diluent. Subsequently, 50 ~tl ofa FDC-PI cell suspension (4 x 10-S/ml) was added to each culture well. Control preparations consisted of 48 replicate cultures containing 50 ~tl of the FDC-P1 cell suspension and 50 ~tl RPMI 1640 medium supplemented with 5~ HI-FCS. The cultures were incubated at 37 °C for 16 to 20 h in 5~ CO,, after which time 50 gl of[Me-3H]thymidine (Amersham) (25 p_Ci/ml) was added and incubation continued for a further 5 h. [Me-3H]Thymidine incorporation was then determined by harvesting the cells onto glass fibre paper using a MASH II multiple sample harvester (Microbiological Associates, Bethesda, Md., U.S.A.). The dried samples of glass fibre paper were placed into 7 ml of scintillation fluid and fl emission was counted in a liquid scintillation counter (Tricarb, Packard). All IP: 54.70.40.11
On: Sat, 15 Dec 2018 18:30:00 T cell response to murine cytomegalovirus 2553 samples were assayed in quadruplicate. Log~o counts per minute were then plotted against log~0 reciprocal of dilution of test supernatant. Endpoint titres were determined by fitting a line to the linear portion of the curve and reading the logto reciprocal dilution where this line intersects a line 3 standard deviations above the mean background from the 48 control wells containing FDC-PI cells in medium without test supernatant dilutions. Crtotoxicity assays. Previously described protocols for cytotoxicity assays using anti-influenza A/WSN (Yap & Ada, 1977) and anti-MCMV effector cells (Sinickas et al., 1985a) were used. Briefly, 96-well flat-bottomed microtitre trays were seeded with tertiary MEF at 104 cells/0.2 ml DMEM/well 3 days prior to assay. After 2 days in culture the cells were adsorbed with MCMV stock as described for stimulator cell preparations, except that the adsorption volume was 25 ~tl. Sixty min later, 150 ~tl of DMEM supplemented with 6 laCi of 5 ~ Cr (Amersham) was added and incubation continued at 37 °C in special gas for 16 h. Uninfected control MEF were treated in a similar manner, except for no viral adsorption. The target cells were then washed twice, followed by addition of 100 ~tl of fresh DMEM and 100 ~tl antiviral effector cell suspension.
Triplicate cultures were set up for each dilution of antiviral effector cells and incubated for 10 h at 37 °C. ~ Cr release from the targets was measured and lysis calculated using the following formula: ~ lysis of infected or uninfected cells = [(5~Cr counts in presence of effector cells -5~Cr counts released in medium)/(s~Cr counts from water-lysed targets -5~Cr counts released in medium)] × 100.
Antiserum treatments. Cultured MCMV-immune LN cells were harvested, centrifuged and resuspended in EMEM plus 5~ FCS at 4 x 107 cells/ml containing 300 ~1 ofa 1:40 dilution of Thy1.2 antiserum (clone F7D5; Olac, Bicester, U.K.) per 108 cells. After incubation at 4 °C for 45 min, the cells were washed twice and resuspended at 10 v per ml in EMEM plus 5 %o FCS containing a 1:8 dilution of Low-Tox-M rabbit complement (C') (Cedarlane Laboratories, Hornby, Ontario, Canada). After 45 min incubation at 37 °C, the cells were harvested, washed twice and resuspended in EMEM and 10-'* M-2-ME at 5 × l0 T cells/ml in preparation for stimulation of lymphokine production. Seven lal of undiluted Lyt2 antiserum 3. 168 (Sarmiento et al., 1980) (generously donated by J. Allen) was added to 0.95 ml cultured MCMV-immune LN cells suspended in EMEM plus 5~o FCS at 1.4 x l0 t' cells/ml. Treatment of cells subsequent to this step was as described for Thy1.2 antiserum and C' treatment, except that a 1:6 dilution of C' was used during the lyric phase.
Concanavalin A-stimulated spleen cell supernatant ( CSS). This was prepared as previously described (Sinickas et al., 1985a) using spleen cells from WEHI-3 mice.
RESULTS

Effect of different numbers of MCMV-inJected or uninfected MEF upon lymphokine release from MCMV-immune LN cells
Preliminary experiments investigated the optimal conditions for stimulation of (Fig. 1) . The results for the two other mouse strains tested were similar to the data obtained for B10.AQR. All subsequent lymphokine release experiments utilized 2 x l0 s MCMV-infected and uninfected MEF stimulators with 5 × l0 s MCMV-immune LN cells in a total volume of 200 gl.
Kinetics of IL-3 release after stimulation of MCMV-immune LN cells with MCMV-infected or uninjected MEF
The temporal relationship between antigenic stimulation and IL-3 release from MCMVimmune LN cells was examined, so that an appropriate time point for harvest of reaction The results (Fig. 2) showed a maximum rate of increase in IL-3 titre between 1 and 8 h after stimulation began. There was a further, slower increase in IL-3 titre until 14 h. With uninfected BALB/c MEF stimulators there was a maximum rate of increase of IL-3 titre from 1 to 4 h and a further, slower increase until 14 h, although the IL-3 titre reached was much lower than with infected MEF.
For logistic reasons all reaction supernatants were harvested 6 h after cell mixing in subsequent experiments.
Effect of Thyl. 2 and Lyt2 antiserum treatment of MCMV-immune LN cells upon their ability to release IL-3
A batch of BALB/c MCMV-immune LN cells was harvested, divided into four equal portions and treated with C' alone, Thyl. 2 antiserum and C', Lyt2 antiserum and C', or left untreated. ~" BALB/c MCMV-immune LN cells (5 x 105) were suspended in 200 ~tl without syngeneic MCMV-infected or uninfected MEF for 6 h at 37 °C.
:~ log10 IL-3 titres from 5 x 105 MCMV-immune LN cells added to 2 x 105 MCMV-infected or uninfected MEF for 6 h at 37 °C. Data given are the means of quadruplicates + standard deviations (S.D.). (Table 1) revealed that IL-3 release dependent upon recognition of MCMVinfected ME~ involved Thy1.2 ÷, Lyt2 ÷ immune LN cells, a phenotype similar to that of cytotoxic T 13;haphocytes. Thy1.2 antiserum plus complement treatment also resulted in a decrease in tile IL-3 titre released upon stimulation with uninfected MEF or from MCMVimmune LN cells cultured alone, but Lyt2 antiserum and complement did not. These data suggest that Lyt2-, Thyl. 2 + MCMV-immune T cells also exist and release IL-3, but that such cells are not stimulated by MCMV-infected MEF.
H~2 restriction of lL-3 stimulation
MCMV-immune LN cells Were obtained from the B10.T(6R) and CBA/H mouse strains. MCMV-immune LN cells (5 x 105) from each strain were stimulated with 2 x 105 MCMVinfected or uninfected MEF also derived from B10. T(6R) or CBA/H mice. The results (Table 2) showed that when the MCMV-immune LN cells and MEF stimulator cells were syngeneic, infected MEF stimulated considerably more IL-3 release than uninfected MEF. In contrast, when MCMV-immune LN cells and stimulator MEF were allogeneic, infected and uninfected MEF caused similar IL-3 release. These results are consistent with the interpretation that IL-3 release can follow H-2 restricted recognition of MCMV antigens by MCMV-immune T cells. Table 1 . Influenza A/WSN-immune cells were obtained by in vitro restimulation of influenza A/WSN-primed spleen cells (Yap & Ada, 1977 ( Table 3) . Release of IL-3 above the levels caused by uninfected control stimulator cells only occurred when virus-infected stimulator cells were added to immune T cells primed with the same virus, i.e. the immune T cells were virus-specific with respect to MCMV and influenza A/WSN.
Viral specificity of MCMV-immune LN cells
Lyt phenotypes and H-2 restriction patterns of MCMV-immune LN cells that mediate cytotoxicity and release lymphokines
Previous experimentation revealed that the MCMV-immune LN cells generated according to the method described here were also cytotoxic to MCMV-infected MEF (Sinickas et al., 1985a, b) . Therefore, we investigated the phenotypic properties of the LN cell populations that were capable of lymphokine release or cytotoxicity. A batch of BALB/c MCMV-immune LN cells was harvested and divided into three portions which were treated with C' alone, Lyt2 antiserum and C', or left untreated. Samples of each of the three portions were assayed for cytotoxicity on MCMV-infected or uninfected BALB/c MEF. A second sample of each of the three portions was suspended at 5 x 106 cells/ml from which 100 ~tl aliquots were removed and mixed with 2 x 105 MCMV-infected or uninfected BALB/c MEF in a total volume of 200 p.1 in a lymphokine release assay.
The results (Table 4 ) indicated that cytotoxicity against MCMV-infected BALB/c MEF and the ability to release IL-3 upon stimulation with MCMV-infected BALB/c MEF were both largely dependent upon MCMV-immune LN cells of Lyt2 + phenotype. Lyt2-T cells were clearly not a prominent population in the assays used here.
Further characterization of MCMV-immune LN cells was performed by determining whether or not Class I antigens were capable of acting as the restriction element during assay for cytotoxic or lymphokine release functions. MCMV-immune LN cells from BALB/c and B10.AQR mice were harvested, pooled and then divided into equal portions such that each portion (1.2 ml) contained MCMV-immune LN cells obtained from six LN. For assessment of cytotoxic activity a 1/36 aliquot of the six LN equivalents was added to MCMV-infected or uninfected MEF target cells, whilst for lymphokine release assays 5 x 105 MCMV-immune LN cells were mixed with 2 x 105 MCMV-infected or uninfected MEF in a total volume of 200 ktl. T cell response to murine cytomegalovirus 2557 *, $, t As for Tables 1 (*, :~) and 2 (1"). § As for Table 4 (1").
The infected or uninfected MEF used in both assays above were derived from BALB/c, CBA/H and B10.T(6R) mice. Cytotoxic activity (Table 5 ) against MCMV-infected MEF was above levels obtained on uninfected MEF when B10.AQR MCMV-immune LN cells were reacted with BALB/c and B10. T(6R) targets, but this was not observed with CBA/H targets. In fact, there was decreased cytotoxicity on MCMV-infected CBA/H MEF in comparison with uninfected CBA/H MEF. IL-3 release ( Table 5 ) followed a pattern similar to that of cytotoxic activity, except for the finding that similar amounts of IL-3 were released in reactions with either MCMV-infected or uninfected CBA/H MEF. The positive results in the B10. AQR-BALB/c combination showed that D region Class I H-2 gene(s) code for restriction antigens involved in MCMV-specific T cell stimulation. Whether K region Class I H-2 genes are also involved has not yet been determined. The negative results for IL-3 release in the B10. AQR-CBA/H combination which shares Class II H-2 genes does not exclude the existence of Class II H-2-restricted anti-MCMV T cells, since MEF do not display Class II H-2 antigens (Vignaux & Gresser, 1978) . (Ada et al., 1976) and herpes simplex virus type 1 (Pfizenmaier et al., 1977) indicated that virus-induced antigenic changes recognized by cytotoxic T cells were expressed within 90 min after viral adsorption. It was of interest to examine whether this was also the case for MCMV-infected MEF with respect to their ability to stimulate IL-3 release.
Effect of time after MCMV infection upon the ability of MEF to stimulate IL-3 release from MCMV-immune LN cells Previous reports with ectromelia virus
BALB/c MEF were adsorbed with MCMV as described in Methods, and incubated for 0, 1, 2, 4, 6, 8, 16 or 24 h before trypsinization, u.v. irradiation and utilization at 2 x 105 cells/100 ~tl to stimulate 5 x 105 BALB/c MCMV-immune LN cells in a total volume of 200 ~tl. Uninfected BALB/c MEF stimulators were treated in a similar manner, except that virus was not adsorbed. Cell-free supernatants were harvested after 6 h and assayed for IL-3.
The results (Fig. 3) revealed maximum release of IL-3 from MCMV-immune LN cells when stimulated with syngeneic MEF infected with MCMV for 8 to 24 h, but it seemed that there was antigen capable of stimulation by 1 h after MCMV infection, assuming that u.v. irradiation of the stimulator MEF arrested any further antigenic expression.
Comparison of ability of different numbers of 3 h or 18 h MCMV-infected BALB/c MEF to stimulate IL-3 release from syngeneic MCMV-immune LN cells
BALB/c MEF were infected with MCMV for either 3 h or 18 h prior to trypsinization and u.v. irradiation. These cells were resuspended at 2 x 10 ~ cells/ml, twofold dilutions performed, and 5 x 105 MCMV-immune BALB/c LN cells added to a total volume of 200 ~tl. After 6 h incubation cell-free supernatants were collected and assayed for IL-3. The results (Fig. 4) showed that for a fixed number of MCMV-immune LN cells, 18 h MCMV-infected BALB/c MEF, at all cell numbers, were capable of stimulating more IL-3 release than 3 h MCMV-infected BALB/c MEF. The amounts of IL-3 released for 18 h MCMVinfected BALB/c MEF reached a maximum at 2.5 x 105 to 5.0 x 105 cells/well, whereas 3 h MCMV-infected BALB/c MEF peaked at 5 x 105 cells/well. With uninfected BALB/c MEF stimulators, IL-3 titres were less than 1.02.
DISCUSSION
It has been shown by other workers (Lafferty et al., 1980a, b ) that release of soluble T cell factors (generally termed lymphokines) from alloantigen-activated T cells is triggered by an antigenic signal. We have shown here that H-2-restricted, antiviral T cells release the lymphokine IL-3 (a multipotential growth factor for lymphomyeloid cells) when stimulated in vitro with syngeneic MCMV-infected MEF and have conducted a detailed investigation of this phenomenon.
Using MCMV infection of mice as the model, it was shown that the release of IL-3 was dependent upon a Thyl. 2 +, Lyt2 ÷ immune LN cell population and that antigen recognition by those T cells was MCMV-specific and Class I, H-2-restricted when MCMV-infected MEF were used as stimulator cells (Tables 1, 2 and 3) . These data are consistent with but do not prove that the same T cells are capable of performing both cytotoxicity and IL-3 release functions. There is some precedent for this phenomenon in viral immunology, since anti-influenza A virus Lyt2 + cytotoxic T cell clones are capable of cytotoxicity and release of the lymphokine, ?-interferon, upon stimulation with virus-infected H-2-matched stimulator cells (Morris et al., 1982) . Proof that the same MCMV-immune T cells are capable of both functions awaits establishment of anti-MCMV cytotoxic T cell clones. Nevertheless, these investigations emphasize further that the Lyt2 ÷ phenotype does not necessarily correlate only with the specific function of cytotoxicity as originally suggested by Cantor & Boyse (1975) .
The H-2 restriction pattern clearly indicated that H-2D ~ acted as a restriction element for MCMV-immune T cells but we have not yet investigated H-2K antigens. Because MEF do not possess Class II antigens on the cell surface, these current experiments do not investigate the presence or absence of Class II-restricted MCMV-immune T cells. Data suggesting that Class II H-2-restricted Lyt2-anti-MCMV T cells were also present in immune LN cell populations will be the subject of a future report. Currently, we are attempting to obtain cell populations that express Class II MHC and MCMV-specific antigens for use as stimulators of IL-3 release or targets for cytotoxicity.
With a fixed number of MCMV-immune T cells, stimulation with increasing numbers of MCMV-infected MEF caused a linear increase in IL-3 titres, plotted on a log-log scale. It is noteworthy that this curve is typical of a single-hit relationship between two interacting species. As IL-3 release is almost certainly dependent upon T cell-stimulator cell conjugate formation, the curve can be easily explained by assuming that one stimulator cell is sufficient to trigger IL-3 release from one cell. Thus, the early region of the curve represents T cell excess and IL-3 titre is directly proportional to the number of stimulator cells added, whilst the plateau results from the maximum stimulation of all antigen-reactive T cells. This simple behaviour is not always the case, as some alloreactive T cell-stimulator cell combinations display more complex kinetic characteristics (P. Hodgkin, unpublished results). The reasons for the decreased IL-3 titre produced at high numbers of MCMV-infected MEF cells is unclear, but may reflect an in vitro artefact rather than the release of inhibitors during the 6 h assay period, because no evidence for inhibitor production was seen for up to 24 h of interaction between T and stimulator cells (Fig. 2) .
The effect of different time intervals between infection of MEF with MCMV and their utilization as stimulators of MCMV-immune T cells is of interest. The results indicated that as time after MEF infection was increased, the capacity to stimulate IL-3 release from MCMVimmune T cells was increased (Fig. 3) . Three possible explanations for this phenomenon are proposed. (i) The rate of lymphokine release can vary with the amount of antigenic stimulus received by the T cell. As antigen per stimulator cell increases, the rate of IL-3 release is increased. (ii) The MCMV-immune T cell population is heterogeneous, with a proportion of cells capable of recognizing 'early' expressed MCMV antigens. At later times the cumulative effect of T cell stimulation by all MCMV antigens is seen. (iii) At early times less MEF are expressing MCMV antigen and therefore more 3 h MCMV-infected stimulators are required to achieve equivalence with the number of stimulators present in the 18 h MCMV-infected MEF population. Theoretically, it is possible to distinguish models (i) and (ii) from model (iii) by a study of the antigen dose-response characteristics. Models (i) and (ii) predict that in the plateau region of antigen excess a difference will be seen between 3 h and 18 h MCMV-infected stimulator-induced lymphokine release. For model (i) this difference would reflect the different rate of lymphokine release and for model (ii) it would indicate the proportion of'early' antigen-
